BridgeBio Oncology Therapeutics (BBOT) Property, Plant & Equipment (Net) (2024 - 2026)

BridgeBio Oncology Therapeutics (BBOT) Property, Plant & Equipment (Net) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.96 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 34.61 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.64 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3.76 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 554.14 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 107.22 Mn
10 BridgeBio Oncology Therapeutics 726.38 Mn 500.67 Mn - 878,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 878,000.00
Jun 30, 2026 878,000.00
Mar 31, 2026 938,000.00
Mar 31, 2026 938,000.00
Dec 31, 2025 956,000.00
Dec 31, 2025 956,000.00
Sep 30, 2025 827,000.00
Sep 30, 2025 827,000.00
Dec 31, 2024 490,000.00
Dec 31, 2024 490,000.00